BamSEC and AlphaSense Join Forces
Learn More

Revance Therapeutics Inc.

NASDAQ: RVNC    
Share price (1/8/25): $3.39    
Market cap (1/8/25): $356 million

Transcripts

CY 2024
CY 2023
CY 2022
CY 2021
CY 2020
Other Revised 11/10/20 Revance Therapeutics, Inc. Presents at 29th Annual Virtual Healthcare Conference, Nov-10-2020 10:15 AM 11/10/20 Earnings Revised 11/09/20 Revance Therapeutics, Inc., Q3 2020 Earnings Call, Nov 09, 2020 11/09/20 Other Revised 10/14/20 Revance Therapeutics, Inc. - Special Call 10/14/20 Other Revised 09/14/20 Revance Therapeutics, Inc. Presents at Morgan Stanley 18th Annual Global Healthcare Conference, Sep-14-2020 05:15 PM 09/14/20 Other Revised 09/09/20 Revance Therapeutics, Inc. Presents at Wells Fargo Securities 2020 Virtual Healthcare Conference, Sep-09-2020 01:20 PM 09/09/20 Earnings Revised 08/06/20 Revance Therapeutics, Inc., Q2 2020 Earnings Call, Aug 06, 2020 08/06/20 Other Revised 06/09/20 Revance Therapeutics, Inc. Presents at Goldman Sachs 41st Annual Global Healthcare Conference, Jun-09-2020 12:50 PM 06/09/20 Other Revised 05/19/20 Hint Inc., Revance Therapeutics, Inc. - M&A Call 05/19/20 Other Revised 05/14/20 Revance Therapeutics, Inc. - Shareholder/Analyst Call 05/14/20 Earnings Revised 05/07/20 Revance Therapeutics, Inc., Q1 2020 Earnings Call, May 07, 2020 05/07/20 Other Revised 03/10/20 Revance Therapeutics, Inc. Presents at Barclays Global Healthcare Conference, Mar-10-2020 01:35 PM 03/10/20 Earnings Revised 02/24/20 Revance Therapeutics, Inc., Q4 2019 Earnings Call, Feb 24, 2020 02/24/20 Other Revised 01/16/20 Revance Therapeutics, Inc. Presents at 38th Annual J.P Morgan Healthcare Conference, Jan-13-2020 through Jan-16-2020 01/16/20 Other Revised 01/10/20 Revance Therapeutics, Inc. - Special Call 01/10/20
CY 2019
CY 2018
CY 2017
CY 2016
CY 2015
CY 2014